Listed

Enanta Pharmaceuticals Inc

ENTANasdaqCIK 1177648HealthcareFiscal year ends Sep 30

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$14.4m, Q3 FY2026
Operating income−$17.2m, Q3 FY2026
Net income−$19.5m, Q3 FY2026
Line itemUnitQ4 FY20232023-09-30Q1 FY20242023-12-31Q2 FY20242024-03-31Q3 FY20242024-06-30Q4 FY20242024-09-30Q1 FY20252024-12-31Q2 FY20252025-03-31Q3 FY20252025-06-30Q4 FY20252025-09-30Q1 FY20262025-12-31Q2 FY20262026-03-31Q3 FY20262026-06-30
Revenue$m18.9Revenue, Q4 FY2023, three months to 2023-09-30$18.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-11-19, accession 0001193125-25-288121. Derived: 12-month figure less the 9-month figure.Report this figure18.0Revenue, Q1 FY2024, three months to 2023-12-31$18.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-02-12, accession 0000950170-25-018810.Report this figure17.1Revenue, Q2 FY2024, three months to 2024-03-31$17.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-14, accession 0000950170-25-071340.Report this figure18.0Revenue, Q3 FY2024, three months to 2024-06-30$18.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-13, accession 0001193125-25-179795.Report this figure14.6Revenue, Q4 FY2024, three months to 2024-09-30$14.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-11-19, accession 0001193125-25-288121. Derived: 12-month figure less the 9-month figure.Report this figure17.0Revenue, Q1 FY2025, three months to 2024-12-31$17.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-11, accession 0001193125-26-046502.Report this figure14.9Revenue, Q2 FY2025, three months to 2025-03-31$14.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001193125-26-220572.Report this figure18.3Revenue, Q3 FY2025, three months to 2025-06-30$18.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure15.1Revenue, Q4 FY2025, three months to 2025-09-30$15.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-11-19, accession 0001193125-25-288121. Derived: 12-month figure less the 9-month figure.Report this figure18.6Revenue, Q1 FY2026, three months to 2025-12-31$18.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-11, accession 0001193125-26-046502.Report this figure17.2Revenue, Q2 FY2026, three months to 2026-03-31$17.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001193125-26-220572.Report this figure14.4Revenue, Q3 FY2026, three months to 2026-06-30$14.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure
Research and development$m36.2Research and development, Q4 FY2023, three months to 2023-09-30$36.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-11-19, accession 0001193125-25-288121. Derived: 12-month figure less the 9-month figure.Report this figure36.4Research and development, Q1 FY2024, three months to 2023-12-31$36.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-02-12, accession 0000950170-25-018810.Report this figure35.6Research and development, Q2 FY2024, three months to 2024-03-31$35.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0000950170-25-071340.Report this figure28.7Research and development, Q3 FY2024, three months to 2024-06-30$28.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-13, accession 0001193125-25-179795.Report this figure30.8Research and development, Q4 FY2024, three months to 2024-09-30$30.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-11-19, accession 0001193125-25-288121. Derived: 12-month figure less the 9-month figure.Report this figure27.7Research and development, Q1 FY2025, three months to 2024-12-31$27.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-11, accession 0001193125-26-046502.Report this figure28.1Research and development, Q2 FY2025, three months to 2025-03-31$28.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001193125-26-220572.Report this figure27.2Research and development, Q3 FY2025, three months to 2025-06-30$27.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure23.8Research and development, Q4 FY2025, three months to 2025-09-30$23.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-11-19, accession 0001193125-25-288121. Derived: 12-month figure less the 9-month figure.Report this figure20.9Research and development, Q1 FY2026, three months to 2025-12-31$20.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-11, accession 0001193125-26-046502.Report this figure19.4Research and development, Q2 FY2026, three months to 2026-03-31$19.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001193125-26-220572.Report this figure22.1Research and development, Q3 FY2026, three months to 2026-06-30$22.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure
Operating income$m(31.0)Operating income, Q4 FY2023, three months to 2023-09-30−$31.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-11-19, accession 0001193125-25-288121. Derived: 12-month figure less the 9-month figure.Report this figure(34.9)Operating income, Q1 FY2024, three months to 2023-12-31−$34.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-02-12, accession 0000950170-25-018810.Report this figure(32.8)Operating income, Q2 FY2024, three months to 2024-03-31−$32.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0000950170-25-071340.Report this figure(24.2)Operating income, Q3 FY2024, three months to 2024-06-30−$24.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-13, accession 0001193125-25-179795.Report this figure(29.9)Operating income, Q4 FY2024, three months to 2024-09-30−$29.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-11-19, accession 0001193125-25-288121. Derived: 12-month figure less the 9-month figure.Report this figure(23.5)Operating income, Q1 FY2025, three months to 2024-12-31−$23.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-11, accession 0001193125-26-046502.Report this figure(24.5)Operating income, Q2 FY2025, three months to 2025-03-31−$24.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001193125-26-220572.Report this figure(18.9)Operating income, Q3 FY2025, three months to 2025-06-30−$18.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure(18.4)Operating income, Q4 FY2025, three months to 2025-09-30−$18.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-11-19, accession 0001193125-25-288121. Derived: 12-month figure less the 9-month figure.Report this figure(11.3)Operating income, Q1 FY2026, three months to 2025-12-31−$11.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-11, accession 0001193125-26-046502.Report this figure(11.9)Operating income, Q2 FY2026, three months to 2026-03-31−$11.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001193125-26-220572.Report this figure(17.2)Operating income, Q3 FY2026, three months to 2026-06-30−$17.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure
Interest expense$m3.2Interest expense, Q4 FY2023, three months to 2023-09-30$3.2m. XBRL concept us-gaap:InterestExpense. 10-K filed 2023-11-22, accession 0000950170-23-065884. Derived: 12-month figure less the 9-month figure.Report this figure3.4Interest expense, Q1 FY2024, three months to 2023-12-31$3.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-02-08, accession 0000950170-24-012796.Report this figure2.6Interest expense, Q2 FY2024, three months to 2024-03-31$2.6m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-08, accession 0000950170-24-055581.Report this figure2.4Interest expense, Q3 FY2024, three months to 2024-06-30$2.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-07, accession 0000950170-24-092714.Report this figure2.6Interest expense, Q4 FY2024, three months to 2024-09-30$2.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2025-11-19, accession 0001193125-25-288121. Derived: 12-month figure less the 9-month figure.Report this figure2.0Interest expense, Q1 FY2025, three months to 2024-12-31$2.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-02-11, accession 0001193125-26-046502.Report this figure1.7Interest expense, Q2 FY2025, three months to 2025-03-31$1.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-13, accession 0001193125-26-220572.Report this figure1.6Interest expense, Q3 FY2025, three months to 2025-06-30$1.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure2.4Interest expense, Q4 FY2025, three months to 2025-09-30$2.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2025-11-19, accession 0001193125-25-288121. Derived: 12-month figure less the 9-month figure.Report this figure3.1Interest expense, Q1 FY2026, three months to 2025-12-31$3.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-02-11, accession 0001193125-26-046502.Report this figure3.3Interest expense, Q2 FY2026, three months to 2026-03-31$3.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-13, accession 0001193125-26-220572.Report this figure4.1Interest expense, Q3 FY2026, three months to 2026-06-30$4.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure
Income tax$m(1.4)Income tax, Q4 FY2023, three months to 2023-09-30−$1.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-11-19, accession 0001193125-25-288121. Derived: 12-month figure less the 9-month figure.Report this figure(0.6)Income tax, Q1 FY2024, three months to 2023-12-31−$622.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-02-12, accession 0000950170-25-018810.Report this figure(0.4)Income tax, Q2 FY2024, three months to 2024-03-31−$363.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-14, accession 0000950170-25-071340.Report this figure(0.4)Income tax, Q3 FY2024, three months to 2024-06-30−$395.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-13, accession 0001193125-25-179795.Report this figure(0.4)Income tax, Q4 FY2024, three months to 2024-09-30−$363.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-11-19, accession 0001193125-25-288121. Derived: 12-month figure less the 9-month figure.Report this figure(0.4)Income tax, Q1 FY2025, three months to 2024-12-31−$416.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-02-11, accession 0001193125-26-046502.Report this figure(1.3)Income tax, Q2 FY2025, three months to 2025-03-31−$1.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-13, accession 0001193125-26-220572.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-06-30$29.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-09-30$32.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-11-19, accession 0001193125-25-288121. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2025-12-31$24.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-02-11, accession 0001193125-26-046502.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-03-31$7.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-13, accession 0001193125-26-220572.Report this figure0.0Income tax, Q3 FY2026, three months to 2026-06-30$36.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure
Net income$m(28.1)Net income, Q4 FY2023, three months to 2023-09-30−$28.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-11-19, accession 0001193125-25-288121. Derived: 12-month figure less the 9-month figure.Report this figure(33.4)Net income, Q1 FY2024, three months to 2023-12-31−$33.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-13, accession 0001193125-25-179795.Report this figure(31.2)Net income, Q2 FY2024, three months to 2024-03-31−$31.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-13, accession 0001193125-25-179795.Report this figure(22.7)Net income, Q3 FY2024, three months to 2024-06-30−$22.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-13, accession 0001193125-25-179795.Report this figure(28.8)Net income, Q4 FY2024, three months to 2024-09-30−$28.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-11-19, accession 0001193125-25-288121. Derived: 12-month figure less the 9-month figure.Report this figure(22.3)Net income, Q1 FY2025, three months to 2024-12-31−$22.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure(22.6)Net income, Q2 FY2025, three months to 2025-03-31−$22.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure(18.3)Net income, Q3 FY2025, three months to 2025-06-30−$18.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure(18.7)Net income, Q4 FY2025, three months to 2025-09-30−$18.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345719. Derived: 12-month figure less the 9-month figure.Report this figure(11.9)Net income, Q1 FY2026, three months to 2025-12-31−$11.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure(13.1)Net income, Q2 FY2026, three months to 2026-03-31−$13.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure(19.5)Net income, Q3 FY2026, three months to 2026-06-30−$19.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure
Diluted EPS$ per sharenot reported(1.58)Diluted EPS, Q1 FY2024, three months to 2023-12-31−$1.58 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-02-12, accession 0000950170-25-018810.Report this figure(1.47)Diluted EPS, Q2 FY2024, three months to 2024-03-31−$1.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0000950170-25-071340.Report this figure(1.07)Diluted EPS, Q3 FY2024, three months to 2024-06-30−$1.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-13, accession 0001193125-25-179795.Report this figurenot reported(1.05)Diluted EPS, Q1 FY2025, three months to 2024-12-31−$1.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-11, accession 0001193125-26-046502.Report this figure(1.06)Diluted EPS, Q2 FY2025, three months to 2025-03-31−$1.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001193125-26-220572.Report this figure(0.85)Diluted EPS, Q3 FY2025, three months to 2025-06-30−$0.85 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figurenot reported(0.42)Diluted EPS, Q1 FY2026, three months to 2025-12-31−$0.42 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-11, accession 0001193125-26-046502.Report this figure(0.45)Diluted EPS, Q2 FY2026, three months to 2026-03-31−$0.45 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001193125-26-220572.Report this figure(0.67)Diluted EPS, Q3 FY2026, three months to 2026-06-30−$0.67 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure
Basic EPS$ per sharenot reported(1.58)Basic EPS, Q1 FY2024, three months to 2023-12-31−$1.58 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-02-12, accession 0000950170-25-018810.Report this figure(1.47)Basic EPS, Q2 FY2024, three months to 2024-03-31−$1.47 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0000950170-25-071340.Report this figure(1.07)Basic EPS, Q3 FY2024, three months to 2024-06-30−$1.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-13, accession 0001193125-25-179795.Report this figurenot reported(1.05)Basic EPS, Q1 FY2025, three months to 2024-12-31−$1.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-11, accession 0001193125-26-046502.Report this figure(1.06)Basic EPS, Q2 FY2025, three months to 2025-03-31−$1.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001193125-26-220572.Report this figure(0.85)Basic EPS, Q3 FY2025, three months to 2025-06-30−$0.85 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figurenot reported(0.42)Basic EPS, Q1 FY2026, three months to 2025-12-31−$0.42 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-11, accession 0001193125-26-046502.Report this figure(0.45)Basic EPS, Q2 FY2026, three months to 2026-03-31−$0.45 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001193125-26-220572.Report this figure(0.67)Basic EPS, Q3 FY2026, three months to 2026-06-30−$0.67 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure

Balance sheet

Cash and equivalents$33.4m, Q3 FY2026
Shareholders' equity$101.1m, Q3 FY2026
Line itemUnitFY20232023-09-30Q1 FY20242023-12-31Q2 FY20242024-03-31Q3 FY20242024-06-30FY20242024-09-30Q1 FY20252024-12-31Q2 FY20252025-03-31Q3 FY20252025-06-30FY20252025-09-30Q1 FY20262025-12-31Q2 FY20262026-03-31Q3 FY20262026-06-30
Cash and equivalents$m85.4Cash and equivalents, FY2023, at 2023-09-30$85.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2024-11-27, accession 0000950170-24-131260.Report this figure39.9Cash and equivalents, Q1 FY2024, at 2023-12-31$39.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-02-08, accession 0000950170-24-012796.Report this figure63.5Cash and equivalents, Q2 FY2024, at 2024-03-31$63.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-08, accession 0000950170-24-055581.Report this figure35.8Cash and equivalents, Q3 FY2024, at 2024-06-30$35.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-07, accession 0000950170-24-092714.Report this figure37.2Cash and equivalents, FY2024, at 2024-09-30$37.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-11-19, accession 0001193125-25-288121.Report this figure84.3Cash and equivalents, Q1 FY2025, at 2024-12-31$84.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-02-12, accession 0000950170-25-018810.Report this figure60.2Cash and equivalents, Q2 FY2025, at 2025-03-31$60.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0000950170-25-071340.Report this figure44.8Cash and equivalents, Q3 FY2025, at 2025-06-30$44.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-13, accession 0001193125-25-179795.Report this figure32.3Cash and equivalents, FY2025, at 2025-09-30$32.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure37.4Cash and equivalents, Q1 FY2026, at 2025-12-31$37.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-02-11, accession 0001193125-26-046502.Report this figure34.9Cash and equivalents, Q2 FY2026, at 2026-03-31$34.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001193125-26-220572.Report this figure33.4Cash and equivalents, Q3 FY2026, at 2026-06-30$33.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure
Current assets$m423Current assets, FY2023, at 2023-09-30$422.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2024-11-27, accession 0000950170-24-131260.Report this figure390Current assets, Q1 FY2024, at 2023-12-31$390.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-02-08, accession 0000950170-24-012796.Report this figure351Current assets, Q2 FY2024, at 2024-03-31$351.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-08, accession 0000950170-24-055581.Report this figure287Current assets, Q3 FY2024, at 2024-06-30$286.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-07, accession 0000950170-24-092714.Report this figure300Current assets, FY2024, at 2024-09-30$299.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-11-19, accession 0001193125-25-288121.Report this figure268Current assets, Q1 FY2025, at 2024-12-31$268.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-02-12, accession 0000950170-25-018810.Report this figure243Current assets, Q2 FY2025, at 2025-03-31$242.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0000950170-25-071340.Report this figure223Current assets, Q3 FY2025, at 2025-06-30$222.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-13, accession 0001193125-25-179795.Report this figure204Current assets, FY2025, at 2025-09-30$204.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure199Current assets, Q1 FY2026, at 2025-12-31$198.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-02-11, accession 0001193125-26-046502.Report this figure178Current assets, Q2 FY2026, at 2026-03-31$178.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-13, accession 0001193125-26-220572.Report this figure204Current assets, Q3 FY2026, at 2026-06-30$203.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure
Total assets$m462Total assets, FY2023, at 2023-09-30$462.3m. XBRL concept us-gaap:Assets. 10-K filed 2024-11-27, accession 0000950170-24-131260.Report this figure428Total assets, Q1 FY2024, at 2023-12-31$428.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-02-08, accession 0000950170-24-012796.Report this figure414Total assets, Q2 FY2024, at 2024-03-31$413.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-08, accession 0000950170-24-055581.Report this figure399Total assets, Q3 FY2024, at 2024-06-30$398.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-07, accession 0000950170-24-092714.Report this figure377Total assets, FY2024, at 2024-09-30$376.7m. XBRL concept us-gaap:Assets. 10-K filed 2025-11-19, accession 0001193125-25-288121.Report this figure349Total assets, Q1 FY2025, at 2024-12-31$348.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-02-12, accession 0000950170-25-018810.Report this figure323Total assets, Q2 FY2025, at 2025-03-31$323.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0000950170-25-071340.Report this figure301Total assets, Q3 FY2025, at 2025-06-30$301.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-13, accession 0001193125-25-179795.Report this figure281Total assets, FY2025, at 2025-09-30$280.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure330Total assets, Q1 FY2026, at 2025-12-31$329.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-02-11, accession 0001193125-26-046502.Report this figure315Total assets, Q2 FY2026, at 2026-03-31$314.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-13, accession 0001193125-26-220572.Report this figure297Total assets, Q3 FY2026, at 2026-06-30$296.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure
Current liabilities$m62.8Current liabilities, FY2023, at 2023-09-30$62.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2024-11-27, accession 0000950170-24-131260.Report this figure62.4Current liabilities, Q1 FY2024, at 2023-12-31$62.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-02-08, accession 0000950170-24-012796.Report this figure54.6Current liabilities, Q2 FY2024, at 2024-03-31$54.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-08, accession 0000950170-24-055581.Report this figure58.2Current liabilities, Q3 FY2024, at 2024-06-30$58.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-07, accession 0000950170-24-092714.Report this figure57.5Current liabilities, FY2024, at 2024-09-30$57.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-11-19, accession 0001193125-25-288121.Report this figure49.1Current liabilities, Q1 FY2025, at 2024-12-31$49.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-02-12, accession 0000950170-25-018810.Report this figure45.9Current liabilities, Q2 FY2025, at 2025-03-31$45.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0000950170-25-071340.Report this figure44.5Current liabilities, Q3 FY2025, at 2025-06-30$44.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-13, accession 0001193125-25-179795.Report this figure48.6Current liabilities, FY2025, at 2025-09-30$48.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure44.7Current liabilities, Q1 FY2026, at 2025-12-31$44.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-02-11, accession 0001193125-26-046502.Report this figure46.4Current liabilities, Q2 FY2026, at 2026-03-31$46.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-13, accession 0001193125-26-220572.Report this figure54.2Current liabilities, Q3 FY2026, at 2026-06-30$54.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure
Total liabilities$m246Total liabilities, FY2023, at 2023-09-30$245.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2024-11-27, accession 0000950170-24-131260.Report this figure237Total liabilities, Q1 FY2024, at 2023-12-31$236.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-02-08, accession 0000950170-24-012796.Report this figure247Total liabilities, Q2 FY2024, at 2024-03-31$247.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-08, accession 0000950170-24-055581.Report this figure250Total liabilities, Q3 FY2024, at 2024-06-30$249.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-07, accession 0000950170-24-092714.Report this figure248Total liabilities, FY2024, at 2024-09-30$247.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-11-19, accession 0001193125-25-288121.Report this figure237Total liabilities, Q1 FY2025, at 2024-12-31$236.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-02-12, accession 0000950170-25-018810.Report this figure229Total liabilities, Q2 FY2025, at 2025-03-31$229.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0000950170-25-071340.Report this figure222Total liabilities, Q3 FY2025, at 2025-06-30$221.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-13, accession 0001193125-25-179795.Report this figure216Total liabilities, FY2025, at 2025-09-30$216.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure203Total liabilities, Q1 FY2026, at 2025-12-31$202.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-02-11, accession 0001193125-26-046502.Report this figure198Total liabilities, Q2 FY2026, at 2026-03-31$198.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-13, accession 0001193125-26-220572.Report this figure196Total liabilities, Q3 FY2026, at 2026-06-30$195.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure
Shareholders' equity$m217Shareholders' equity, FY2023, at 2023-09-30$216.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-11-19, accession 0001193125-25-288121.Report this figure192Shareholders' equity, Q1 FY2024, at 2023-12-31$191.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-13, accession 0001193125-25-179795.Report this figure166Shareholders' equity, Q2 FY2024, at 2024-03-31$166.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-13, accession 0001193125-25-179795.Report this figure149Shareholders' equity, Q3 FY2024, at 2024-06-30$148.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-13, accession 0001193125-25-179795.Report this figure129Shareholders' equity, FY2024, at 2024-09-30$128.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure112Shareholders' equity, Q1 FY2025, at 2024-12-31$111.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure93.5Shareholders' equity, Q2 FY2025, at 2025-03-31$93.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure79.3Shareholders' equity, Q3 FY2025, at 2025-06-30$79.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure64.7Shareholders' equity, FY2025, at 2025-09-30$64.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure127Shareholders' equity, Q1 FY2026, at 2025-12-31$126.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure117Shareholders' equity, Q2 FY2026, at 2026-03-31$116.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure101Shareholders' equity, Q3 FY2026, at 2026-06-30$101.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure

Cash flow

Operating cash flow−$10.0m, Q3 FY2026
Capital expenditure$7.0k, Q3 FY2026
Line itemUnitQ4 FY20232023-09-30Q1 FY20242023-12-31Q2 FY20242024-03-31Q3 FY20242024-06-30Q4 FY20242024-09-30Q1 FY20252024-12-31Q2 FY20252025-03-31Q3 FY20252025-06-30Q4 FY20252025-09-30Q1 FY20262025-12-31Q2 FY20262026-03-31Q3 FY20262026-06-30
Operating cash flow$m(21.6)Operating cash flow, Q4 FY2023, three months to 2023-09-30−$21.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-11-19, accession 0001193125-25-288121. Derived: 12-month figure less the 9-month figure.Report this figure(25.0)Operating cash flow, Q1 FY2024, three months to 2023-12-31−$25.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-02-12, accession 0000950170-25-018810.Report this figure(28.6)Operating cash flow, Q2 FY2024, three months to 2024-03-31−$28.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0000950170-25-071340. Derived: 6-month figure less the 3-month figure.Report this figure(14.8)Operating cash flow, Q3 FY2024, three months to 2024-06-30−$14.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-13, accession 0001193125-25-179795. Derived: 9-month figure less the 6-month figure.Report this figure(10.4)Operating cash flow, Q4 FY2024, three months to 2024-09-30−$10.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-11-19, accession 0001193125-25-288121. Derived: 12-month figure less the 9-month figure.Report this figure(16.8)Operating cash flow, Q1 FY2025, three months to 2024-12-31−$16.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-11, accession 0001193125-26-046502.Report this figure(13.5)Operating cash flow, Q2 FY2025, three months to 2025-03-31−$13.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001193125-26-220572. Derived: 6-month figure less the 3-month figure.Report this figure17.5Operating cash flow, Q3 FY2025, three months to 2025-06-30$17.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001193125-26-345719. Derived: 9-month figure less the 6-month figure.Report this figure(6.5)Operating cash flow, Q4 FY2025, three months to 2025-09-30−$6.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-11-19, accession 0001193125-25-288121. Derived: 12-month figure less the 9-month figure.Report this figure(11.7)Operating cash flow, Q1 FY2026, three months to 2025-12-31−$11.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-11, accession 0001193125-26-046502.Report this figure(7.2)Operating cash flow, Q2 FY2026, three months to 2026-03-31−$7.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001193125-26-220572. Derived: 6-month figure less the 3-month figure.Report this figure(10.0)Operating cash flow, Q3 FY2026, three months to 2026-06-30−$10.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001193125-26-345719. Derived: 9-month figure less the 6-month figure.Report this figure
Capital expenditure$m1.4Capital expenditure, Q4 FY2023, three months to 2023-09-30$1.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-11-19, accession 0001193125-25-288121. Derived: 12-month figure less the 9-month figure.Report this figure0.8Capital expenditure, Q1 FY2024, three months to 2023-12-31$787.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-02-12, accession 0000950170-25-018810.Report this figure1.7Capital expenditure, Q2 FY2024, three months to 2024-03-31$1.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-14, accession 0000950170-25-071340. Derived: 6-month figure less the 3-month figure.Report this figure6.5Capital expenditure, Q3 FY2024, three months to 2024-06-30$6.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-13, accession 0001193125-25-179795. Derived: 9-month figure less the 6-month figure.Report this figure9.0Capital expenditure, Q4 FY2024, three months to 2024-09-30$9.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-11-19, accession 0001193125-25-288121. Derived: 12-month figure less the 9-month figure.Report this figure8.7Capital expenditure, Q1 FY2025, three months to 2024-12-31$8.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-11, accession 0001193125-26-046502.Report this figure2.5Capital expenditure, Q2 FY2025, three months to 2025-03-31$2.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001193125-26-220572. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2025, three months to 2025-06-30$155.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0001193125-26-345719. Derived: 9-month figure less the 6-month figure.Report this figure1.5Capital expenditure, Q4 FY2025, three months to 2025-09-30$1.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-11-19, accession 0001193125-25-288121. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2026, three months to 2025-12-31$143.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-11, accession 0001193125-26-046502.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-03-31$15.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001193125-26-220572. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2026, three months to 2026-06-30$7.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0001193125-26-345719. Derived: 9-month figure less the 6-month figure.Report this figure

Shares

Diluted shares (weighted)29.09m, Q3 FY2026
Line itemUnitQ1 FY20232022-12-31Q2 FY20232023-03-31Q3 FY20232023-06-30Q1 FY20242023-12-31Q2 FY20242024-03-31Q3 FY20242024-06-30Q1 FY20252024-12-31Q2 FY20252025-03-31Q3 FY20252025-06-30Q1 FY20262025-12-31Q2 FY20262026-03-31Q3 FY20262026-06-30
Diluted shares (weighted)m shares20.8Diluted shares (weighted), Q1 FY2023, three months to 2022-12-3120,816,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-02-08, accession 0000950170-24-012796.Report this figure21.0Diluted shares (weighted), Q2 FY2023, three months to 2023-03-3121,035,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-08, accession 0000950170-24-055581.Report this figure21.1Diluted shares (weighted), Q3 FY2023, three months to 2023-06-3021,054,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-07, accession 0000950170-24-092714.Report this figure21.1Diluted shares (weighted), Q1 FY2024, three months to 2023-12-3121,088,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-02-12, accession 0000950170-25-018810.Report this figure21.2Diluted shares (weighted), Q2 FY2024, three months to 2024-03-3121,167,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-14, accession 0000950170-25-071340.Report this figure21.2Diluted shares (weighted), Q3 FY2024, three months to 2024-06-3021,180,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-13, accession 0001193125-25-179795.Report this figure21.2Diluted shares (weighted), Q1 FY2025, three months to 2024-12-3121,238,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-11, accession 0001193125-26-046502.Report this figure21.4Diluted shares (weighted), Q2 FY2025, three months to 2025-03-3121,355,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001193125-26-220572.Report this figure21.4Diluted shares (weighted), Q3 FY2025, three months to 2025-06-3021,377,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure28.7Diluted shares (weighted), Q1 FY2026, three months to 2025-12-3128,748,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-11, accession 0001193125-26-046502.Report this figure29.0Diluted shares (weighted), Q2 FY2026, three months to 2026-03-3129,040,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001193125-26-220572.Report this figure29.1Diluted shares (weighted), Q3 FY2026, three months to 2026-06-3029,090,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure

Shares outstanding: 29.13mShares outstanding, period not labelled, at 2026-08-0729,125,402 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-12, accession 0001193125-26-345719.Report this figure at Aug 7, 2026, from the cover of the 10-Q filed Aug 12, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. Listed shows no prices and gives no investment advice.